Rigel Pharmaceuticals logo

Rigel Pharmaceuticals Share Price Today

(NASDAQ: RIGL)

Rigel Pharmaceuticals share price is $20.29 & ₹1,764.60 as on 6 Mar 2025, 2.30 'hrs' IST

$20.29

-1.79

(-8.11%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Rigel Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Rigel Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Rigel Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Rigel Pharmaceuticals share price movements

  • Today's Low: $19.01
    Today's High: $21.41

    Day's Volatility :11.19%

  • 52 Weeks Low: $7.48
    52 Weeks High: $29.82

    52 Weeks Volatility :74.9%

Rigel Pharmaceuticals (RIGL) Returns

PeriodRigel Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
-22.05%
3.7%
0.0%
6 Months
51.3%
-2.8%
0.0%
1 Year
30.06%
2.5%
0.0%
3 Years
-34.34%
12.9%
-11.6%

Rigel Pharmaceuticals (RIGL) Key Statistics

in dollars & INR

Previous Close
$22.08
Open
$20.15
Today's High
$21.405
Today's Low
$19.01
Market Capitalization
$388.9M
Today's Volume
$577.9K
52 Week High
$29.82
52 Week Low
$7.4843
Revenue TTM
$157.4M
EBITDA
$11.3M
Earnings Per Share (EPS)
$0.27
PE Ratio
81.78
Profit Margin
2.47%
Quarterly Earnings Growth YOY
-0.48%
Return On Equity TTM
-699.05%

How to invest in Rigel Pharmaceuticals Stock (RIGL) from India?

It is very easy for Indian residents to invest directly in Rigel Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Rigel Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Rigel Pharmaceuticals or RIGL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Rigel Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Rigel Pharmaceuticals shares which would translate to 0.043 fractional shares of Rigel Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Rigel Pharmaceuticals, in just a few clicks!

Returns in Rigel Pharmaceuticals (RIGL) for Indian investors in Rupees

The Rigel Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Rigel Pharmaceuticals investment value today

Current value as on today

₹1,35,013

Returns

₹35,013

(+35.01%)

Returns from Rigel Pharmaceuticals Stock

₹30,064 (+30.06%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Rigel Pharmaceuticals (RIGL)

-44%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Rigel Pharmaceuticals Stock from India on INDmoney has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Rigel Pharmaceuticals

  • BlackRock Inc

    9.92%

  • Morgan Stanley - Brokerage Accounts

    8.86%

  • Armistice Capital, LLC

    6.54%

  • Soleus Capital Management, L.P.

    6.42%

  • Vanguard Group Inc

    5.75%

  • Assenagon Asset Management SA

    2.33%

Analyst Recommendation on Rigel Pharmaceuticals

Buy

    58%Buy

    41%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Rigel Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
5
5
5
Sell
0
0
0

Analyst Forecast on Rigel Pharmaceuticals Stock (RIGL)

What analysts predicted

Upside of 57.71%

Target:

$32.00

Current:

$20.29

Insights on Rigel Pharmaceuticals Stock (Ticker Symbol: RIGL)

  • Price Movement

    In the last 6 months, RIGL stock has moved up by 52.3%
  • Increasing Revenue

    Revenue is up for the last 4 quarters, 29.53M → 57.59M (in $), with an average increase of 19.1% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, -8.24M → 14.34M (in $), with an average increase of 274.1% per quarter
  • RIGL vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 36.4%
  • RIGL vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 84.9%
  • Price to Sales

    ForRIGL every $1 of sales, investors are willing to pay $2.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Rigel Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Rigel Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Rigel Pharmaceuticals (RIGL) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Rigel Pharmaceuticals Inc logo
-2.73%
51.3%
30.06%
-34.34%
2.99%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Rigel Pharmaceuticals Inc logo
81.78
81.78
-0.1
1.4
-6.99
0.05
NA
-0.83
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Rigel Pharmaceuticals Inc logo
Buy
$388.9M
2.99%
81.78
2.47%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Rigel Pharmaceuticals

Rigel Pharmaceuticals, Inc., a biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer. The company's commercialized products include Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia; Rezlidhia, a non-intensive monotherapy for the treatment of adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test; and GAVRETO, a once daily, small molecule, oral, kinase inhibitor for the treatment of adult patients with metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer, as well as for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET fusion-positive thyroid cancer. It also develops R289, an oral IRAK1/4 Inhibitor, which is in Phase 1b clinical trials for the treatment of hematology-oncology, autoimmune, and inflammatory diseases; and a receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor program in clinical development with partner Eli Lilly and Company. In addition, the company has product candidates in clinical development with partners BerGenBio ASA and Daiichi Sankyo. The company has strategic development collaboration with The University of Texas MD Anderson Cancer Center for the development of REZLIDHIA (Olutasidenib) in acute myeloid leukemia (AML) and other hematologic cancers. The company was incorporated in 1996 and is headquartered in South San Francisco, California.
Organization
Rigel Pharmaceuticals
Employees
147
CEO
Mr. Raul R. Rodriguez
Industry
Health Technology

Management People of Rigel Pharmaceuticals

NameTitle
Mr. Raul R. Rodriguez
President, CEO & Director
Mr. Dean L. Schorno CPA
Executive VP & CFO
Mr. Raymond J. Furey J.D.
Executive VP, General Counsel & Corporate Secretary
Mr. David A. Santos
Executive VP & Chief Commercial Officer
Ms. Julie Patel
Senior VP of Human Resources
Dr. Esteban S. Masuda Ph.D.
Executive Vice President of Research
Mr. Joseph Lasaga
Executive VP & Chief Business Officer
Dr. Lisa Rojkjaer M.D.
Executive VP & Chief Medical Officer
Mr. Tarek Sallam
Vice President of Marketing

Important FAQs about investing in RIGL Stock from India :

What is Rigel Pharmaceuticals share price today?

Rigel Pharmaceuticals share price today stands at $20.29, Open: $20.15 ; Previous Close: $22.08 ; High: $21.41 ; Low: $19.01 ; 52 Week High: $29.82 ; 52 Week Low: $7.48.

The stock opens at $20.15, after a previous close of $22.08. The stock reached a daily high of $21.41 and a low of $19.01, with a 52-week high of $29.82 and a 52-week low of $7.48.

Can Indians buy Rigel Pharmaceuticals shares?

Yes, Indians can invest in the Rigel Pharmaceuticals (RIGL) from India.

With INDmoney, you can buy Rigel Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Rigel Pharmaceuticals at zero transaction cost.

How can I buy Rigel Pharmaceuticals shares from India?

It is very easy to buy Rigel Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Rigel Pharmaceuticals (RIGL) be purchased?

Yes, you can buy fractional shares of Rigel Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Rigel Pharmaceuticals stocks?

To start investing in Rigel Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Rigel Pharmaceuticals Stock (RIGL)?

Today’s highest price of Rigel Pharmaceuticals (RIGL) is $21.41.

Today’s lowest price of Rigel Pharmaceuticals (RIGL) is $19.01.

What is today's market capitalisation of Rigel Pharmaceuticals?

Today's market capitalisation of Rigel Pharmaceuticals RIGL is 388.9M

What is the 52 Week High and Low Range of Rigel Pharmaceuticals Stock (RIGL)?

  • 52 Week High

    $29.82

  • 52 Week Low

    $7.48

What are the historical returns of Rigel Pharmaceuticals (RIGL)?

  • 1 Month Returns

    -2.73%

  • 3 Months Returns

    51.3%

  • 1 Year Returns

    30.06%

  • 5 Years Returns

    2.99%

Who is the Chief Executive Officer (CEO) of Rigel Pharmaceuticals ?

Mr. Raul R. Rodriguez is the current Chief Executive Officer (CEO) of Rigel Pharmaceuticals.